Vast Therapeutics

0 followers


Vast is a preclinical biotechnology company focused on treating the world’s most challenging drug-resistant microbial infections that represent one of the greatest threats to global health, food security, and economic development.

Industries

Employees

11-50

Links

Org chart

Nate Stasko

Collapse
Mark Schoenfisch
Chief Scientific Officer
John Simons
VP, Product Development
Stan Hollenbach
VP, Translational Science
Rebecca Anthouard McDonald, PhD
Director of Bacteriology